Richard J. Napolitano - Apr 1, 2022 Form 4/A - Amendment Insider Report for Teladoc Health, Inc. (TDOC)

Role
CHIEF ACCOUNTING OFFICER
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
Apr 1, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
5/2/2022, 04:12 PM
Date Of Original Report
Apr 4, 2022
Previous filing
Mar 2, 2022
Next filing
Jun 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Award $0 +6.78K $0.00 6.78K Apr 1, 2022 Common Stock 6.78K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F2 One-third of the restricted stock units vest on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F3 On April 4, 2022, the reporting person filed a Form 4 which inadvertently reported that the restricted stock units will vest on March 1, 2022, with the remainder vesting in eight substantially equal quarterly installments thereafter, instead of on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter.